China Bans Illumina DNA Sequencers Amid US Tariff Escalation
China has banned the import of Illumina’s DNA sequencers in retaliation to new US tariffs, following its earlier designation of the company as an 'unreliable entity.' Illumina maintains that the ban will not stop its operations in China, while it assesses the financial impact.
Published on March 28, 2025
China has imposed a ban on the import of Illumina’s DNA sequencing instruments in response to additional US tariffs. The measure follows earlier actions that saw the company added to Beijing’s 'unreliable entities' list after the initial imposition of 10% tariffs under President Donald Trump. Illumina has reassured stakeholders that the ban does not hinder its ongoing operations in China and that it is evaluating the potential impact on its business.
Additional reporting from early March 2025 has highlighted further economic repercussions. A Reuters report from March 10 noted that in light of the ban, Illumina had lowered its annual profit forecast and announced a $100 million cost reduction program. In separate coverage, Reuters mentioned board changes on March 25, with activist investor Keith Meister set to join the board as part of strategic adjustments during this challenging period. These developments underscore the broader tensions between the US and China over trade and technology transfer issues.